67
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Successful treatment of relapsed testicular embryonal rhabdomyosarcoma with Endostar and traditional chemotherapy: a case report

, , , , , , , & show all
Pages 5287-5291 | Published online: 30 Aug 2018

References

  • SultanIQaddoumiIYaserSRodriguez-GalindoCFerrariAComparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patientsJ Clin Oncol200927203391339719398574
  • vonMMRandallRLBenjaminRSSoft tissue sarcoma, version 2.2018J Natl Compr Canc Netw201816553656329752328
  • AthbunRCLockhartSMStephensJRRhabdomyosarcoma in adults: new perspectives on therapyCurr Treat Options Oncol2015166342
  • BrennanMFAlektiarKMMakiRGCancer: Principles & Practice of OncologyNew YorkLippincott Williams & Wilkins2011
  • Limaverde-SousaGSternbergCFerreiraCGAntiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agentsCancer Treat Rev201440454855724360358
  • FolkmanJRole of angiogenesis in tumor growth and metastasisSemin Oncol2002296 Suppl 161518
  • GeeMFTsuchidaREichler-JonssonCVascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acidOncogene200524548025803716116481
  • SchiavettiAMcdowellHPContiLVascular endothelial growth factor serum levels in children with newly diagnosed rhabdomyosarcomaPediatr Blood Cancer201259462763022231858
  • GantiRSkapekSXZhangJExpression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcomaMod Pathol20061991213122016729016
  • CroseLESLinardicCMReceptor tyrosine kinases as therapeutic targets in rhabdomyosarcomaSarcoma20102011714X1357
  • XingPZhangJYanZRecombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IVOncotarget2017822367163672727888623
  • TengCLiLIShenWPleural synovial sarcoma patient treated with combined chemotherapy and Endostar, plus sunitinib maintenance therapy: a case report and review of the literatureOncol Lett20151021141114426622640
  • ZhangLPLiaoXYXuYMEfficacy and safety of Endostar® combined with chemotherapy in patients with advanced soft tissue sarcomasAsian Pac J Cancer Prev20131474255425923991986
  • RuymannFBThe development of VAC chemotherapy in rhabdomyosarcoma: what does one do for an encore?Curr Oncol Rep20035650550914521810
  • OberlinOReyALydenEPrognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groupsJ Clin Oncol200826142384238918467730
  • ZhanXKZhangSCaoBWClinicopathological characteristics and treatment outcomes of Chinese patients with genitourinary embryonal rhabdomyosarcomaWorld J Surg Oncol201513119026018798
  • KojimaYHashimotoKAndoMClinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapyJ Cancer Res Clin Oncol201213871249125722441933
  • LiuZWZhangXQHouGLPrimary adult intratesticular rhabdomyosarcoma: results of the treatment of six casesInt J Urol201118217117421272089